Rep. Daniel S. Goldman sold Madrigal Pharmaceuticals (MDGL)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Apr 10, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Apr 10, 2023
- Disclosed
- May 19, 2023
- Days to disclose
- 39
- Asset type
- Stock
- As filed
- Madrigal Pharmaceuticals, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Goldman's trades →- May 19, 2023$250K–$500K
Bought N Y ST ENV FACS CORP REV 5% 05/15/26 MN
$250K–$500K · Traded Apr 26, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold SOUTH ORANGE VLG TWP N J GO 4% 01/15/27
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold HOOVER ALA GO 4% 07/01/36 JJ
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold EWING TWP N J GO 4% 11/15/25 MN
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought SCHENECTADY N Y GO 4% 05/01/26 MN
$100K–$250K · Traded Apr 20, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Sold NEW JERSEY (STATE OF) GO 5% 06/01/28 JD
$100K–$250K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought N Y CITY MUN WTR FIN AUTH REV 5.0000% 06/15/31 JD
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought COLONIE N Y GO 4% 03/08/24 MS
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$500K–$1M
Sold N J ENV INFRASTRUCTURE TR REV 4% 09/01/27-CA MS
$500K–$1M · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought TELSTRA GROUP LTD SPONSORED ADR CMN (TLGPY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought SOFTBANK CORP. ADR CMN (SOBKY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought DORM AUTH OF THE STATE OF NY REV 5.0000% 10/01/26 AO
$250K–$500K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$15K–$50K
$15K–$50K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$50K–$100K
$50K–$100K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Computershare Limited CMSQY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Qantas Airways Limited QABSY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Sold (partial) MIAMI-DADE CNTY FLA 5% 07-01- 2025 BEO
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought West Japan Railway Company WJRYY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Central Japan Railway Company CJPRY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought LOCKPORT CITY N Y SCH DIST GO 5% 04/15/28 AO
$100K–$250K · Traded Apr 12, 2023 · disclosed May 19, 2023
Company context for MDGL
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
MDGL: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP reported buying shares
5 reported purchases of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
MDGL: third_quarter 2026 lobbying report
FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
Public: Oct 20, 2026, 3:55 PM EDTOriginal source ↗MDGL: third_quarter 2026 lobbying report
Issues related to CMMI drug pricing; 340B drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing
Public: Oct 19, 2026, 3:46 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.